VolitionRx Limited Operating Cash Flow
VolitionRx Limited (VNRX) reported Operating Cash Flow of -$10.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- VolitionRx Limited net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.16M.
- VolitionRx Limited net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.28M.
- VolitionRx Limited net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.49M.
- VolitionRx Limited net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.63M.
- VolitionRx Limited net cash provided by (used in) operating activities for fiscal 2025 was -$19.68M.
- VolitionRx Limited net cash provided by (used in) operating activities for fiscal 2024 was -$25.89M.
- VolitionRx Limited net cash provided by (used in) operating activities for fiscal 2023 was -$18.06M.
- VolitionRx Limited net cash provided by (used in) operating activities for fiscal 2022 was -$15.28M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 17 month | Net Cash Provided by (Used in) Operating Activities 20 month | Net Cash Provided by (Used in) Operating Activities 23 month | Net Cash Provided by (Used in) Operating Activities 26 month | Net Cash Provided by (Used in) Operating Activities 29 month | Net Cash Provided by (Used in) Operating Activities 32 month | Net Cash Provided by (Used in) Operating Activities 35 month | Net Cash Provided by (Used in) Operating Activities 38 month | Net Cash Provided by (Used in) Operating Activities 41 month | Net Cash Provided by (Used in) Operating Activities 44 month | Net Cash Provided by (Used in) Operating Activities 47 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$5.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$10.44M 10-Q · filed 2026-08-13 | -$15.93M derived: sum of 3 quarters · filed 2026-08-13 | -$19.56M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2026-03-31 | -$5.28M 10-Q · filed 2026-05-14 | -$10.77M derived: sum of 2 quarters · filed 2026-05-14 | -$14.40M derived: sum of 3 quarters · filed 2026-05-14 | -$20.67M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-12-31 | -$5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$9.12M derived: sum of 2 quarters · filed 2026-03-31 | -$15.39M derived: sum of 3 quarters · filed 2026-08-13 | -$19.68M 10-K · filed 2026-03-31 | ||||||||||||||||
| 2025-09-30 | -$3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$9.89M derived: sum of 2 quarters · filed 2026-08-13 | -$14.19M 10-Q · filed 2025-11-13 | -$19.62M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-06-30 | -$6.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$10.56M 10-Q · filed 2026-08-13 | -$15.99M derived: sum of 3 quarters · filed 2026-08-13 | -$21.38M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-03-31 | -$4.30M 10-Q · filed 2026-05-14 | -$9.73M derived: sum of 2 quarters · filed 2026-05-14 | -$15.12M derived: sum of 3 quarters · filed 2026-05-14 | -$21.85M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||||||||
| 2024-12-31 | -$5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$10.82M derived: sum of 2 quarters · filed 2026-03-31 | -$17.55M derived: sum of 3 quarters · filed 2026-03-31 | -$25.89M 10-K · filed 2026-03-31 | ||||||||||||||||
| 2024-09-30 | -$5.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$12.12M derived: sum of 2 quarters · filed 2025-11-13 | -$20.46M 10-Q · filed 2025-11-13 | -$14.01M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||||
| 2024-06-30 | -$6.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$15.07M 10-Q · filed 2025-08-14 | -$8.63M derived: sum of 3 quarters · filed 2025-08-14 | -$17.05M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||||
| 2024-03-31 | -$8.34M 10-Q · filed 2025-05-15 | -$1.89M derived: sum of 2 quarters · filed 2025-05-15 | -$10.31M derived: sum of 3 quarters · filed 2025-05-15 | -$17.66M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||||
| 2023-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.97M derived: sum of 2 quarters · filed 2025-03-31 | -$9.32M derived: sum of 3 quarters · filed 2025-03-31 | -$18.06M 10-K · filed 2025-03-31 | ||||||||||||||||
| 2023-09-30 | -$8.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$15.77M derived: sum of 2 quarters · filed 2024-11-14 | -$24.51M 10-Q · filed 2024-11-14 | -$30.31M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||||||
| 2023-06-30 | -$7.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$16.09M 10-Q · filed 2024-08-14 | -$21.90M derived: sum of 3 quarters · filed 2024-08-14 | -$28.72M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||||||
| 2023-03-31 | -$8.74M 10-Q · filed 2024-05-13 | -$14.55M derived: sum of 2 quarters · filed 2024-05-13 | -$21.37M derived: sum of 3 quarters · filed 2024-05-13 | -$27.63M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||||||
| 2022-12-31 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$12.62M derived: sum of 2 quarters · filed 2024-03-25 | -$18.89M derived: sum of 3 quarters · filed 2024-03-25 | -$15.28M 10-K · filed 2024-03-25 | ||||||||||||||||
| 2022-09-30 | -$6.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$13.08M derived: sum of 2 quarters · filed 2023-11-14 | -$9.47M 10-Q · filed 2023-11-14 | -$10.09M 10-Q · filed 2022-11-14 | -$13.88M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.65M 10-Q · filed 2023-08-14 | -$3.28M 10-Q · filed 2022-08-10 | -$7.06M derived: sum of 3 quarters · filed 2023-08-14 | -$11.94M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||||
| 2022-03-31 | $3.61M 10-Q · filed 2023-05-10 | $2.99M 10-Q · filed 2022-05-11 | -$799.01K derived: sum of 2 quarters · filed 2023-05-10 | -$5.68M derived: sum of 3 quarters · filed 2023-05-10 | -$11.08M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2021-12-31 | -$4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$9.29M derived: sum of 2 quarters · filed 2023-03-15 | -$14.69M derived: sum of 3 quarters · filed 2023-03-15 | -$20.85M 10-K · filed 2023-03-15 | ||||||||||||||||
| 2021-09-30 | -$4.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$10.28M derived: sum of 2 quarters · filed 2022-11-14 | -$16.44M 10-Q · filed 2022-11-14 | -$19.18M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||||||
| 2021-06-30 | -$5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$11.57M 10-Q · filed 2022-08-10 | -$14.30M derived: sum of 3 quarters · filed 2022-08-10 | -$18.80M derived: sum of 4 quarters · filed 2022-08-10 | ||||||||||||||||
| 2021-03-31 | -$6.17M 10-Q · filed 2022-05-11 | -$8.90M derived: sum of 2 quarters · filed 2022-05-11 | -$13.40M derived: sum of 3 quarters · filed 2022-05-11 | -$17.83M derived: sum of 4 quarters · filed 2022-05-11 | ||||||||||||||||
| 2020-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$7.23M derived: sum of 2 quarters · filed 2022-03-30 | -$11.67M derived: sum of 3 quarters · filed 2022-03-30 | -$16.46M 10-K · filed 2022-03-30 | ||||||||||||||||
| 2020-09-30 | -$4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$8.93M derived: sum of 2 quarters · filed 2021-11-10 | -$13.73M 10-Q · filed 2021-11-10 | -$16.33M derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||||||
| 2020-06-30 | -$4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$9.23M 10-Q · filed 2021-08-11 | -$11.83M derived: sum of 3 quarters · filed 2021-08-11 | -$15.55M derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||||||
| 2020-03-31 | -$4.80M 10-Q · filed 2021-05-11 | -$7.40M derived: sum of 2 quarters · filed 2021-05-11 | -$11.11M derived: sum of 3 quarters · filed 2021-05-11 | -$13.89M derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||||||||
| 2019-12-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$6.32M derived: sum of 2 quarters · filed 2021-03-22 | -$9.09M derived: sum of 3 quarters · filed 2021-03-22 | -$12.74M 10-K · filed 2021-03-22 | ||||||||||||||||
| 2019-09-30 | -$3.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$6.49M derived: sum of 2 quarters · filed 2020-11-12 | -$10.14M 10-Q · filed 2020-11-12 | -$13.77M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||||||||||
| 2019-06-30 | -$2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$6.42M 10-Q · filed 2020-08-13 | -$10.05M derived: sum of 3 quarters · filed 2020-08-13 | -$14.67M derived: sum of 4 quarters · filed 2020-08-13 | ||||||||||||||||
| 2019-03-31 | -$3.65M 10-Q · filed 2020-05-07 | -$7.28M derived: sum of 2 quarters · filed 2020-05-07 | -$11.89M derived: sum of 3 quarters · filed 2020-05-07 | -$14.88M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||||||
| 2018-12-31 | -$3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$8.24M derived: sum of 2 quarters · filed 2020-02-20 | -$11.23M derived: sum of 3 quarters · filed 2020-02-20 | -$14.73M 10-K · filed 2020-02-20 | ||||||||||||||||
| 2018-09-30 | -$4.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$7.60M derived: sum of 2 quarters · filed 2019-11-12 | -$11.10M 10-Q · filed 2019-11-12 | -$14.99M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||||
| 2018-06-30 | -$2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$6.49M 10-Q · filed 2019-08-12 | -$10.38M derived: sum of 3 quarters · filed 2019-08-12 | -$13.20M derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||||||||
| 2018-03-31 | -$3.51M 10-Q · filed 2019-05-08 | -$7.39M derived: sum of 2 quarters · filed 2019-05-08 | -$10.22M derived: sum of 3 quarters · filed 2019-05-08 | -$13.03M derived: sum of 4 quarters · filed 2019-05-08 | ||||||||||||||||
| 2017-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$6.71M derived: sum of 2 quarters · filed 2019-03-13 | -$9.52M derived: sum of 3 quarters · filed 2019-03-13 | -$12.19M 10-K · filed 2019-03-13 | ||||||||||||||||
| 2017-09-30 | -$2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$5.64M derived: sum of 2 quarters · filed 2018-11-07 | -$8.31M 10-Q · filed 2018-11-07 | -$10.50M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||||||
| 2017-06-30 | -$2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$5.48M 10-Q · filed 2018-08-13 | -$7.67M derived: sum of 3 quarters · filed 2018-08-13 | -$9.79M derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||||
| 2017-03-31 | -$2.67M 10-Q · filed 2018-05-10 | -$4.86M derived: sum of 2 quarters · filed 2018-05-10 | -$6.98M derived: sum of 3 quarters · filed 2018-05-10 | -$9.37M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||||||||||
| 2016-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$4.31M derived: sum of 2 quarters · filed 2018-03-01 | -$6.70M derived: sum of 3 quarters · filed 2018-03-01 | -$8.86M 10-K · filed 2018-03-01 | -$9.06M 10-K · filed 2017-03-10 | |||||||||||||||
| 2016-09-30 | -$2.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$4.51M derived: sum of 2 quarters · filed 2017-11-09 | -$6.67M 10-Q · filed 2017-11-09 | -$6.70M 10-Q · filed 2016-11-10 | -$8.74M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||||
| 2016-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$4.56M 10-Q · filed 2017-08-10 | -$6.62M derived: sum of 3 quarters · filed 2017-08-10 | -$8.97M derived: sum of 4 quarters · filed 2017-08-10 | ||||||||||||||||
| 2016-03-31 | -$2.16M 10-Q · filed 2017-05-11 | -$4.23M derived: sum of 2 quarters · filed 2017-05-11 | -$6.57M derived: sum of 3 quarters · filed 2017-05-11 | -$8.50M derived: sum of 4 quarters · filed 2017-05-11 | ||||||||||||||||
| 2015-12-31 | -$2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$4.41M derived: sum of 2 quarters · filed 2017-03-10 | -$6.34M derived: sum of 3 quarters · filed 2017-03-10 | -$8.55M 10-K · filed 2017-03-10 | -$8.77M 10-K · filed 2016-03-11 | |||||||||||||||
| 2015-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$4.27M derived: sum of 2 quarters · filed 2016-11-10 | -$6.48M 10-Q · filed 2016-11-10 | -$6.68M 10-Q · filed 2015-11-04 | -$7.47M derived: sum of 4 quarters · filed 2016-11-10 | |||||||||||||||
| 2015-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$4.14M 10-Q · filed 2016-08-11 | -$5.13M derived: sum of 3 quarters · filed 2016-08-11 | -$5.99M derived: sum of 4 quarters · filed 2016-08-11 | ||||||||||||||||
| 2015-03-31 | -$2.21M 10-Q · filed 2016-05-13 | -$3.20M derived: sum of 2 quarters · filed 2016-05-13 | -$4.06M derived: sum of 3 quarters · filed 2016-05-13 | -$5.37M derived: sum of 4 quarters · filed 2016-05-13 | ||||||||||||||||
| 2014-12-31 | -$992.67K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$1.86M derived: sum of 2 quarters · filed 2016-03-11 | -$3.16M derived: sum of 3 quarters · filed 2016-03-11 | -$4.14M 10-K · filed 2016-03-11 | ||||||||||||||||
| 2014-09-30 | -$863.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$2.17M derived: sum of 2 quarters · filed 2015-11-04 | -$3.15M 10-Q · filed 2015-11-04 | -$3.86M derived: sum of 4 quarters · filed 2015-11-04 | ||||||||||||||||
| 2014-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$2.28M 10-Q · filed 2015-08-11 | -$2.99M derived: sum of 3 quarters · filed 2015-08-11 | -$3.82M derived: sum of 4 quarters · filed 2015-08-11 | -$9.51M 10-Q · filed 2014-08-01 | |||||||||||||||
| 2014-03-31 | -$977.56K 10-Q · filed 2015-05-12 | -$1.69M derived: sum of 2 quarters · filed 2015-05-12 | -$2.51M derived: sum of 3 quarters · filed 2015-05-12 | -$3.51M derived: sum of 4 quarters · filed 2015-05-12 | -$8.21M 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | -$709.27K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | -$1.54M derived: sum of 2 quarters · filed 2015-03-18 | -$2.53M derived: sum of 3 quarters · filed 2015-03-18 | -$3.08M 10-K · filed 2015-03-18 | -$7.23M 10-K · filed 2014-03-28 | |||||||||||||||
| 2013-09-30 | -$827.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$1.82M derived: sum of 2 quarters · filed 2014-11-06 | -$2.37M 10-Q · filed 2014-11-06 | -$2.82M derived: sum of 4 quarters · filed 2014-11-06 | -$6.66M 10-Q · filed 2013-10-31 | |||||||||||||||
| 2013-06-30 | -$990.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$1.55M 10-Q · filed 2014-08-01 | -$1.99M derived: sum of 3 quarters · filed 2014-08-01 | -$2.72M derived: sum of 4 quarters · filed 2014-08-01 | -$5.83M 10-Q · filed 2013-07-29 | |||||||||||||||
| 2013-03-31 | -$556.35K 10-Q · filed 2014-05-15 | -$1.00M derived: sum of 2 quarters · filed 2014-05-15 | -$1.73M derived: sum of 3 quarters · filed 2014-05-15 | -$2.31M derived: sum of 4 quarters · filed 2014-05-15 | -$4.84M 10-Q · filed 2013-05-06 | |||||||||||||||
| 2012-12-31 | -$447.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$1.17M derived: sum of 2 quarters · filed 2014-03-28 | -$1.75M derived: sum of 3 quarters · filed 2014-03-28 | -$2.31M 10-K · filed 2014-03-28 | -$4.15M 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | -$723.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$1.30M derived: sum of 2 quarters · filed 2013-10-31 | -$1.87M 10-Q · filed 2013-10-31 | -$2.44M derived: sum of 4 quarters · filed 2013-10-31 | -$3.73M 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | -$579.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$1.14M 10-Q · filed 2013-07-29 | -$1.72M derived: sum of 3 quarters · filed 2013-07-29 | -$2.16M derived: sum of 4 quarters · filed 2013-07-29 | -$3.01M 10-Q · filed 2012-08-14 | |||||||||||||||
| 2012-03-31 | -$564.08K 10-Q · filed 2013-05-06 | -$1.14M derived: sum of 2 quarters · filed 2013-05-06 | -$1.58M derived: sum of 3 quarters · filed 2013-05-06 | -$1.88M derived: sum of 4 quarters · filed 2013-05-06 | -$2.43M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | -$573.53K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$1.02M derived: sum of 2 quarters · filed 2013-04-01 | -$1.31M derived: sum of 3 quarters · filed 2013-04-01 | -$1.65M 10-K · filed 2013-04-01 | -$1.69M 10-KT/A · filed 2012-05-08 | -$1.86M 10-KT/A · filed 2012-05-08 | ||||||||||||||
| 2011-09-30 | -$445.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$740.63K derived: sum of 2 quarters · filed 2012-11-14 | -$1.08M 10-Q · filed 2012-11-14 | |||||||||||||||||
| 2011-06-30 | -$295.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$633.75K 10-Q · filed 2012-08-14 | ||||||||||||||||||
| 2011-03-31 | -$338.27K 10-Q · filed 2012-05-15 | |||||||||||||||||||
| 2010-12-31 | -$178.40K 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |